Coronary Artery Disease Clinical Trial
Official title:
The Turkish Adaptation, Validity and Reliability of the Heart Health Self-Efficacy and Self-Management Scale
Verified date | March 2024 |
Source | Karamanoglu Mehmetbey University |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Observational |
The importance of lifestyle changes to control risk factors in the prevention, treatment and management of coronary heart disease (CHD), a major health problem, has been emphasised. In addition, physical, social, psychological and occupational limitations arising from the disease negatively affect the quality of life and self-efficacy perceptions of individuals, making it difficult to comply with treatment and disease management. There are general self-efficacy and self-management scales for which Turkish validity and reliability studies have been conducted previously. However, these scales are not specific to coronary heart disease patients and evaluate either only self-efficacy or only self-management. The aim of this study was to adapt the Heart Health Self-efficacy and Self-Management Scale (HH-SESM) into Turkish and to investigate its validity and reliability in patients with coronary heart disease. The study is conducted in Cardiology outpatient clinics of Karaman Training and Research Hospital. Before the study, the purpose and content of the study will be explained to the participants and an informed consent form will be obtained from the participants. Since the sample size in validity and reliability studies should be at least 10 times the total number of scale items, at least 120 individuals will be included in the study as the number of items x number of options (12 x 10 = 120). Detailed medical history and sociodemographic information (age, gender, height, weight, body mass index, disease duration (months), occupation, daily working hours, educational status, sports/exercise habits) will be recorded. In order to measure self-management and self-efficacy levels, patients will be administered the HH-SESM, Self-care management in chronic diseases scale- Self-care subgroup questions and General self-efficacy scales.
Status | Completed |
Enrollment | 250 |
Est. completion date | December 15, 2023 |
Est. primary completion date | December 15, 2023 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Being diagnosed with coronary heart disease for at least 6 months - Speaking Turkish - to be able to read and write - Being over 18 years old - volunteering to participate in the study Exclusion Criteria: - Having a serious psychiatric illness such as panic disorder or major depression |
Country | Name | City | State |
---|---|---|---|
Turkey | Karamanoglu Mehmetbey University | Karaman |
Lead Sponsor | Collaborator |
---|---|
Karamanoglu Mehmetbey University | Karaman Training and Research Hospital |
Turkey,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | validity and reliability of Turkish Heart Health Self-efficacy and Self-Management Scale | It will be applied to the patients as a questionnaire in order to make the Turkish validity and reliability of the Heart Health Self-efficacy and Self-Management Scale. Scores =36 can be interpreted as high self-efficacy and high self-management. The scale consists of 12 items and is scored using a 4-point Likert system. But since there is also an invalid answer option, people can get a minimum score of 0 and a maximum score of 48. Scores =36 can be interpreted as high self-efficacy and high self-management. Scores between 24 - 35 can be interpreted as adequate self-efficacy and adequate self-management. Scores =24 can be interpreted as low self-efficacy and low self-management. | within 24 hours of admission | |
Secondary | Self-Care Management Scale in chronic diseases | For the external construct validity statistical method, the self-management level of the individuals will be determined with the Self-Care Management in Chronic Diseases Scale, which has been previously validated and reliable in Turkish. The scale consists of 20 items. The scale is analysed over the total score. 5-point Likert system is used in scoring, with 1 point for strongly disagree and 5 points for strongly agree.
Individuals can get a maximum score of 100 and a minimum score of 20. A high score indicates high general self-efficacy; a low score indicates low self-efficacy. |
within 24 hours of admission | |
Secondary | General self-efficacy scale | For the external construct validity statistical method, the self-efficacy level of the individuals will be determined with the general self-efficacy scale, which has been previously validated and reliable in Turkish. The scale consists of 10 items. The scale is analysed over the total score. Points are given to the items according to the answers.
Completely wrong = 1 point Somewhat correct = 2 points Moderately correct = 3 points Completely correct = 4 points Individuals can get a maximum score of 40 and a minimum score of 10. A high score indicates high general self-efficacy; a low score indicates low self-efficacy. |
within 24 hours of admission |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT06030596 -
SPECT Myocardial Blood Flow Quantification for Diagnosis of Ischemic Heart Disease Determined by Fraction Flow Reserve
|
||
Completed |
NCT04080700 -
Korean Prospective Registry for Evaluating the Safety and Efficacy of Distal Radial Approach (KODRA)
|
||
Recruiting |
NCT03810599 -
Patient-reported Outcomes in the Bergen Early Cardiac Rehabilitation Study
|
N/A | |
Recruiting |
NCT06002932 -
Comparison of PROVISIONal 1-stent Strategy With DEB Versus Planned 2-stent Strategy in Coronary Bifurcation Lesions.
|
N/A | |
Not yet recruiting |
NCT06032572 -
Evaluation of the Safety and Effectiveness of the VRS100 System in PCI (ESSENCE)
|
N/A | |
Recruiting |
NCT05308719 -
Nasal Oxygen Therapy After Cardiac Surgery
|
N/A | |
Recruiting |
NCT04242134 -
Drug-coating Balloon Angioplasties for True Coronary Bifurcation Lesions
|
N/A | |
Completed |
NCT04556994 -
Phase 1 Cardiac Rehabilitation With and Without Lower Limb Paddling Effects in Post CABG Patients.
|
N/A | |
Recruiting |
NCT05846893 -
Drug-Coated Balloon vs. Drug-Eluting Stent for Clinical Outcomes in Patients With Large Coronary Artery Disease
|
N/A | |
Recruiting |
NCT06027788 -
CTSN Embolic Protection Trial
|
N/A | |
Recruiting |
NCT05023629 -
STunning After Balloon Occlusion
|
N/A | |
Completed |
NCT04941560 -
Assessing the Association Between Multi-dimension Facial Characteristics and Coronary Artery Diseases
|
||
Completed |
NCT04006288 -
Switching From DAPT to Dual Pathway Inhibition With Low-dose Rivaroxaban in Adjunct to Aspirin in Patients With Coronary Artery Disease
|
Phase 4 | |
Completed |
NCT01860274 -
Meshed Vein Graft Patency Trial - VEST
|
N/A | |
Recruiting |
NCT06174090 -
The Effect of Video Education on Pain, Anxiety and Knowledge Levels of Coronary Bypass Graft Surgery Patients
|
N/A | |
Terminated |
NCT03959072 -
Cardiac Cath Lab Staff Radiation Exposure
|
||
Completed |
NCT03968809 -
Role of Cardioflux in Predicting Coronary Artery Disease (CAD) Outcomes
|
||
Recruiting |
NCT05065073 -
Iso-Osmolar vs. Low-Osmolar Contrast Agents for Optical Coherence Tomography
|
Phase 4 | |
Recruiting |
NCT04566497 -
Assessment of Adverse Outcome in Asymptomatic Patients With Prior Coronary Revascularization Who Have a Systematic Stress Testing Strategy Or a Non-testing Strategy During Long-term Follow-up.
|
N/A | |
Completed |
NCT05096442 -
Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
|
N/A |